Orthokeratology is defined as the use of custom designed (as per the patient

According to the National Health Council, nearly 40% of the adult population in the US is diagnosed with at least one chronic condition, such as diabetes, asthma, and hypertension. The annual cost burden associated with chronic diseases in the US is around USD 3.8 trillion. This has prompted stakeholders to develop devices that enable self-administration of drugs. Amongst the various self-injection devices, autoinjectors have steadily gained prominence, especially for the treatment of emergency...

The 4D bioprinting market, valued at USD 31 million in 2025, is projected to grow to USD 40 million in 2026 and USD 684 million by 2035, representing a CAGR of 37.2% during the forecast period. Owing to the ongoing advancements in the 4D bio fabrication technology, several players are actively adopting and developing 4D bioprinters and smart biomaterials. It is worth highlighting that 4D bioprinting is garnering a lot of attention from academicians and industry players. In fact, the volume of af...

The at home testing kits market, valued at USD 18.21 billion in 2025, is projected to grow to USD 19.24 billion in 2026 and USD 31.15 billion by 2035, representing a CAGR of 5.5% during the forecast period. Since the approval of the first over-the-counter test kits in early 1976, there has been a substantial increase in the development initiatives focused on such products. In this context, it is worth highlighting that over 20 million at-home pregnancy test kits are being annually sold in the US...

The global handheld ultrasound scanners market is estimated to grow from USD 583 million in 2024 to USD 1,142 million by 2030, representing a CAGR of 12% during the forecast period. Point-of-care ultrasound or handheld ultrasound imaging devices emerged as a viable solution to empower clinicians with portable, mobile, and lightweight scanners for disease diagnosis. For instance, Butterfly IQ (an innovative handheld ultrasound scanner) is available at only 2% of the cost of a conventional ultraso...

The drug device combination products market, valued at USD 327 million in 2025, is projected to grow to USD 357 million in 2026 and USD 938 million by 2035, representing a CAGR of 11.3% during the forecast period. Combination products comprise of two or more FDA- regulated components that provide controlled release of the APIs. However, the development of drug-device combination products is a long-drawn-out process that not only requires novel technologies and processes but also a huge amount of...

The global safety syringe and safety needles market, valued at USD 6.80 billion in 2025, is projected to reach USD 6.90 billion in 2026 and USD 8.90 billion by 2035, representing a CAGR of 2.9% during the forecast period. Given the increasing incidence of needlestick injury among patients, there is a surge in the requirement of safety syringes and needles. Safety needles refer to syringes that are specifically designed to reduce the risk of needlestick injuries and enhance safety to prevent the...

The global container closure integrity testing market size is estimated to be worth USD 252 million in 2025 and is expected to reach USD 269 million in 2026 and USD 558 million by 2035 at a CAGR of 8.4% during the forecast period. The market for container closure integrity testing (CCIT) is anticipated to witness outstanding growth over this projection time frame. Majorly, continuous advancement in testing methods can be attributed to elevating the market growth. With more than 40 service provi...

The global pharmaceutical vials market, valued at USD 11.65 billion in 2025, is projected to reach USD 12.33 billion in 2026 and USD 15.85 billion by 2030, with a 6.5% CAGR during the forecast period, 2026 to 2030. Pre-sterilized / ready-to-use (RTU) pharmaceutical vials have emerged as a promising alternative to conventional pharmaceutical vials, adding significant value to streamline pharmaceutical fill / finish operations. It is worth noting that these innovations have significantly helped in...

The global at home blood collection devices market, valued at USD 1,005 million in 2025, is projected to reach USD 1,114 million in 2026 and USD 1,867 million by 2030, with a 13.8% CAGR during the forecast period 2026 to 2030. Post the onset of COVID-19 pandemic, there has been a decline in number of patients visiting laboratories for sample collection and testing. In fact, an average decline of approximately 40% in phlebotomy appointments was reported by various laboratories across the globe....

The ocular drug delivery devices market is expected to grow from USD 964 Mn in 2025 to USD 1,098 Mn in 2026 and USD 1,616 Mn by 2030, at a CAGR of 10.1%. It is also worth highlighting that around 1.7 billion individuals worldwide are expected to lose their vision by 2050. As per the Centers for Disease Control and Prevention (CDC), loss of vision can pose an economic burden of over USD 35 billion, in terms of loss of productivity and direct costs of treatment / care. In fact, over 1,100 patents...

Chronic diseases, such as diabetes, arthritis, hypertension and cancer, are considered among the leading causes of death, worldwide. Lack of adherence to prescribed medication regimens (due to various reasons) and high cost of treatment (a significant share of which stems from non-compliance to treatment), are the major contributing factors to the associated burden on patients and the healthcare system. However, modern therapy administration technology, such as wearable and implantable drug deli...

The medical batteries market, valued at USD 1.64 billion in 2025, is projected to grow to USD 1.85 billion in 2026 and USD 3.10 billion by 2030, representing a CAGR of 13.8% during the forecast period. The exponential growth in wearable medical devices and implants, such as hearing aids, implantable cardiac defibrillators, infusion pumps, neurostimulators and pacemakers, has led to an increase in demand for safe, compact, lightweight and high energy density batteries with better cycle life. Desp...

The portable x ray devices market is estimated to be worth $900 million in 2021 and is expected to grow at CAGR of 13% during the forecast period. Since the discovery of X-rays, the field of medical imaging has evolved significantly, offering a non-invasive means for physicians to accurately visualize almost all major organ systems for diagnostic purposes. Presently, there are a number of handheld X-ray imaging devices available in the market, and several device developers are engaged in efforts...

The blood glucose monitoring devices market size, valued at USD 24.2 billion in 2025, is projected to reach USD 26.5 billion in 2026 and USD 34 billion by 2030, with a CAGR of 6.3% during the forecast period 2026 to 2030. Diabetes is one of the seven leading causes of death and disability across the world. According to the World Health Organization (WHO), more than 1.6 million deaths are directly attributed to diabetes each year. In 2019, the global expenditure on diabetes treatment and disease...

The non invasive diagnostics market for fibrotic diseases is estimated to be worth $1.6 billion in 2020 and is expected to grow at CAGR of 10% during the forecast period. Notably, with non-alcoholic fatty liver disease (NAFLD) (subsequently progressing to nonalcoholic steatohepatitis / NASH drugs) being the primary cause of liver disease, nearly 4.5 million adults in the US have been diagnosed with this condition in 2018. Similarly, idiopathic pulmonary fibrosis (IPF) is a chronic, progressive,...

The non invasive neurostimulation devices market is estimated to be worth $1 billion in 2020 and is expected to grow at CAGR of 11% during the forecast period. Over the past few decades, the prevalence of neurological disorders has been increasing at an alarming rate, particularly among the geriatric population across the world. In fact, nearly 1 million Americans are reported to be living with Parkinson

The AI in medical imaging market size is projected to grow from $1.75 billion in 2024 to $8.56 billion by 2030, growing at a CAGR of 30% during the forecast period from 2024 to 2030. Notably, in situations characterized by low physician / pathologist to patient ratios, the conventional mode of operation is rendered inadequate. Experts have predicted a shortage of 10,000 to 40,000 physicians, by 2030, in the US alone. Over time, various industry stakeholders have designed proprietary deep learnin...

The global diabetes drug delivery devices market, valued at USD 17 billion in 2025, is projected to reach USD 18 billion in 2026 and USD 31 billion by 2030, with a 14.1% CAGR during the forecast period 2026 to 2030. It is worth mentioning that according to the WHO, more than 400 million individuals across the world are currently suffering from diabetes; this number is estimated to reach over 570 million by 2030. Further, in patients with diabetes, glycemic control is required multiple times i...

The regulatory affairs management for medical devices market, valued at USD 594 billion in 2025, is projected to reach USD 633 billion in 2026 and USD 819 billion by 2030, with a 6.7% CAGR during the forecast period 2026 to 2030. According to the World Bank, more than 50,000 different types of medical devices are currently being used on a daily basis in healthcare facilities across the globe. Moreover, in 2018, the USFDA approved over 130 medical devices. However, a relatively large proportion...